Combating Counterfeit Medicines: Siemens Starts Joint Pilot Medicines Coding Project with EFPIA in Sweden
23 October 2009 - 10:00PM
PR Newswire (US)
NORWALK, Conn., Oct. 23 /PRNewswire/ -- This incidence of
counterfeit prescription medicines in Europe's traditional supply
chain is growing. This is why EFPIA (European Federation of
Pharmaceutical Industries and Associations) has launched a pilot
project that includes the testing of a coding and identification
solution in Sweden. Siemens IT Solutions and Services is supplying
the information and communications technology (ICT). This solution
enables counterfeit products to be reliably identified at all times
and monitors the progress of medicines throughout the complete
supply chain. The project is being carried out in partnership with
the retail pharmacy chain Apoteket AB and local wholesalers Tamro
and KD. (Logo:
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ) Up to
now, pharmacists were reliant on visual checks to make sure that
medicines were not counterfeit before dispensing to patients. But
these days will soon be over. In the EFPIA's new coding and
identification solution, pharmacists will check a unique
identification code on each individual pack before it is dispensed
to the patient. This 2D data matrix barcode, with a unique serial
number, can be easily generated and printed on the packaging by the
manufacturer. Scanners are used to read the code and pass it to a
verification system that checks that the pack with that serial
number has not been dispensed before. If it is already marked in
the database as dispensed, the pharmacist is made aware of the
possibility that the pack may be counterfeit, and numbers are found
when scanning the packs, an alert is triggered. Pharmacy staff can
then take the necessary precautions and immediately trigger an
investigation. In the EFPIA pilot project, Siemens IT Solutions and
Services is the general contractor in cooperation with Hewlett
Packard (HP) and SAP. The IT service provider is responsible for
the project management and integration of the information
interfaces between the pharmacies and the manufacturers. Siemens IT
Solutions and Services is also responsible for operating and
maintaining the IT infrastructure, including the technology and
information systems, data integration, system security and system
development. SAP Belgium will be in charge of the SAPĀ® object event
repository (SAP OER) and the implementation services. Hewlett
Packard (HP) will provide hosting services and SAP solutions
testing. The aim is to introduce a standardized coding and
identification solution for the pharmaceutical sector in Europe
that is compliant with existing international and European
standards. If this pilot project is successful, EFPIA will present
it to the EU authorities for replication in the other EU countries
and so create a uniform platform for key players in the European
pharmaceutical industry in the fight against counterfeit medicines.
EFPIA (European Federation of Pharmaceutical Industries and
Associations) represents the pharmaceutical industry operating in
Europe. Through its direct membership of 31 national associations
and 44 leading pharmaceutical companies, EFPIA is the voice on the
EU scene of 2,200 companies committed to researching, developing
and bringing to patients new medicines that will improve health and
the quality of life around the world. The pharmaceutical industry
accounts for no less than 19.2% of global business R&D
expenditure. It is the sector with the highest ratio of R&D
investment to net sales (16.1%). However, between 1990 and 2008,
R&D investment in the United States grew by 460% whilst in
Europe it only increased by 250%, and there is rapid growth in the
research environment in emerging economies such as China and India.
Today around 635,000 people work in this sector and it is estimated
that three to four times more employment is generated indirectly
both upstream and downstream. A significant proportion of people
employed are highly skilled and 117,000 work in research and
development. The European research-based pharmaceutical industry
generates a substantial trade surplus, which was estimated at about
48 billion euros for 2008. It has contributed significantly to
reducing the European Union's trade deficit in high-tech products -
today almost a quarter of the EU's high-tech exports are
pharmaceutical products. Siemens IT Solutions and Services is an
internationally leading provider of IT solutions and services. It
covers the entire IT service chain from a single source, from
consulting to system integration, right through to the management
of IT infrastructures. In addition, Siemens IT Solutions and
Services extends the range of offerings of the other Siemens
Sectors to include IT solutions. With its comprehensive know-how
and industry-specific knowledge, Siemens IT Solutions and Services
provides measurable added value for its customers. Siemens IT
Solutions and Services employs more than 41,000 people and posts
annual sales of about 5.3 billion euros, of which over 70 percent
are generated outside of the Siemens Sectors. More information at
http://www.siemens.com/it-solutions. SAP is the world's leading
provider of business software, offering applications and services
that enable companies of all sizes and in more than 25 industries
to become best-run businesses. With more than 89,000 customers in
over 120 countries, the company is listed on several exchanges,
including the Frankfurt stock exchange and NYSE, under the symbol
"SAP." For more information, visit http://www.sap.com/.
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO
http://photoarchive.ap.org/ DATASOURCE: Siemens IT Solutions and
Services CONTACT: Scott M. Smith, Siemens, , +1-678.327.9864 Web
Site: http://www.siemens.com/it-solutions
Copyright